Valiant Laboratories Limited — Important, 11-08-2025: General Updates

Valiant Laboratories has successfully completed its Rights Issue, allotting 1.09 crore equity shares at ₹75 each. This move raised ₹81.47 crore for the company. Consequently, the paid-up equity share capital has increased from ₹43.45 crore to ₹54.31 crore. The company will now credit shares to allottees' demat accounts. This capital infusion strengthens the company's financial position and supports future growth initiatives.